XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 219,444 $ 175,640
Accounts receivable, inclusive of the blenders’ tax credit of $11,381 and $8,970, and net of allowances for credit losses of $55 and $48, respectively 28,406 26,198
Accounts receivable – related parties 1 6
Inventory 32,978 26,761
Income tax receivable 1,940 1,959
Prepaid expenses 4,346 3,694
Prepaid expenses – related parties 12 12
Marketable securities 0 37,126
Other current assets 3,419 2,380
Total current assets 290,546 273,776
Property, plant and equipment, net 72,711 76,941
Other assets 3,824 5,252
Total noncurrent assets 76,535 82,193
Total Assets 367,081 355,969
Liabilities and Stockholders’ Equity    
Accounts payable 22,178 28,546
Accounts payable – related parties 42 7,799
Deferred revenue – current 3,863 3,772
Dividends payable 10,503 10,503
Accrued expenses and other current liabilities 4,758 5,477
Accrued expenses and other current liabilities – related parties 0 1
Total current liabilities 41,344 56,098
Deferred revenue – non-current 12,570 15,079
Other noncurrent liabilities 3,287 1,792
Total noncurrent liabilities 15,857 16,871
Total liabilities 57,201 72,969
Commitments and contingencies:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding 0 0
Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,763,243 and 43,763,243 issued and outstanding as of December 31, 2023 and 2022 4 4
Accumulated other comprehensive income 0 (1)
Additional paid in capital 282,489 282,489
Retained earnings 27,387 508
Total stockholders’ equity 309,880 283,000
Total Liabilities and Stockholders’ Equity $ 367,081 $ 355,969